Infertility Treatment Devices Market

Executive Summary

Infertility Treatment Devices Market was valued at US $1.63 billion in 2021 and is projected to grow at 8.69% CAGR over the forecast period to reach US $2.69 billion by 2027. Infertility Treatment Devices Market represented US $0.25 billion opportunity over 2019-2021 and estimated to create US $1.06 billion opportunity in 2027 over 2021.

Infertility Treatment Devices from Consainsights analyses the Infertility Treatment Devices Market in the Life Sciences industry over the forecast period to 2027.

Infertility Treatment Devices research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Infertility Treatment Devices segmentation includes Product, Technology, End User and Geography.

Based on the Product, the Infertility Treatment Devices analysis covers Imaging Systems, Sperm Analyzer Systems, Workstations, Ovum Aspiration Pumps, Incubators, Micromanipulator Systems, Gas Analyzers, Laser Systems, Cryosystems, Antivibration Tables, Accessories.

In Product segment, Imaging Systems segment has highest cagr growth of 7.69%.

Based on the Technology, the Infertility Treatment Devices analysis covers In Vitro Fertilization, Artificial Insemination, Intrauterine Insemination, Intracytoplasmic Sperm Injection, Gamete Donation, Surrogacy.

In Technology segment, In Vitro Fertilization segment has highest cagr growth of 7.69%.

Based on the End User, the Infertility Treatment Devices analysis covers Fertility And Surgical Centers, Hospitals And Clinics, Cryobanks.

In End User segment, Fertility And Surgical Centers segment has highest cagr growth of 7.69%.

Based on the region, the Infertility Treatment Devices analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include The Cooper Companies, Inc., Cook Group Incorporated, Thermo Fisher Scientific, Inc., Vitrolife Ab, Research Instruments Limited, Esco Micro Pte. Ltd., Genea Limited, Irvine Scientific, Ivftech Aps, The Baker Company, Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Imaging Systems segment has the highest revenue of US $0.63 billion and is expected to grow at CAGR of 7.69% by 2027 Imaging Systems segment has highest cagr growth of 7.69%.

Imaging Systems

Imaging Systems segment was valued at US $0.54 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $1.04 billion by 2027. Imaging Systems segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.41 billion opportunity in 2027 over 2021.

Sperm Analyzer Systems

Sperm Analyzer Systems segment was valued at US $0.33 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.64 billion by 2027. Sperm Analyzer Systems segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.25 billion opportunity in 2027 over 2021.

Workstations

Workstations segment was valued at US $0.20 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.40 billion by 2027. Workstations segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.16 billion opportunity in 2027 over 2021.

Ovum Aspiration Pumps

Ovum Aspiration Pumps segment was valued at US $0.12 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.24 billion by 2027. Ovum Aspiration Pumps segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.09 billion opportunity in 2027 over 2021.

Incubators

Incubators segment was valued at US $0.08 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.16 billion by 2027. Incubators segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.06 billion opportunity in 2027 over 2021.

Micromanipulator Systems

Micromanipulator Systems segment was valued at US $0.05 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.09 billion by 2027. Micromanipulator Systems segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.04 billion opportunity in 2027 over 2021.

Gas Analyzers

Gas Analyzers segment was valued at US $0.03 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.05 billion by 2027. Gas Analyzers segment represented US $0.00 billion opportunity over 2019-2021 and estimated to create US $0.02 billion opportunity in 2027 over 2021.

Laser Systems

Laser Systems segment was valued at US $0.02 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.03 billion by 2027. Laser Systems segment represented US $0.00 billion opportunity over 2019-2021 and estimated to create US $0.01 billion opportunity in 2027 over 2021.

Cryosystems

Cryosystems segment was valued at US $0.01 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.02 billion by 2027. Cryosystems segment represented US $0.00 billion opportunity over 2019-2021 and estimated to create US $0.01 billion opportunity in 2027 over 2021.

Antivibration Tables

Antivibration Tables segment was valued at US $0.00 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.01 billion by 2027. Antivibration Tables segment represented US $0.00 billion opportunity over 2019-2021 and estimated to create US $0.00 billion opportunity in 2027 over 2021.

Accessories

Accessories segment was valued at US $0.00 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.00 billion by 2027. Accessories segment represented US $0.00 billion opportunity over 2019-2021 and estimated to create US $0.00 billion opportunity in 2027 over 2021.

Technology

Introduction

In 2021, In Vitro Fertilization segment has the highest revenue of US $0.74 billion and is expected to grow at CAGR of 7.69% by 2027 In Vitro Fertilization segment has highest cagr growth of 7.69%.

In Vitro Fertilization

In Vitro Fertilization segment was valued at US $0.62 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $1.22 billion by 2027. In Vitro Fertilization segment represented US $0.11 billion opportunity over 2019-2021 and estimated to create US $0.48 billion opportunity in 2027 over 2021.

Artificial Insemination

Artificial Insemination segment was valued at US $0.38 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.74 billion by 2027. Artificial Insemination segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.29 billion opportunity in 2027 over 2021.

Intrauterine Insemination

Intrauterine Insemination segment was valued at US $0.20 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.40 billion by 2027. Intrauterine Insemination segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.16 billion opportunity in 2027 over 2021.

Intracytoplasmic Sperm Injection

Intracytoplasmic Sperm Injection segment was valued at US $0.11 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.21 billion by 2027. Intracytoplasmic Sperm Injection segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.08 billion opportunity in 2027 over 2021.

Gamete Donation

Gamete Donation segment was valued at US $0.06 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.12 billion by 2027. Gamete Donation segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.05 billion opportunity in 2027 over 2021.

Surrogacy

Surrogacy segment was valued at US $0.00 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.01 billion by 2027. Surrogacy segment represented US $0.00 billion opportunity over 2019-2021 and estimated to create US $0.00 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals And Clinics segment has the highest revenue of US $0.79 billion and is expected to grow at CAGR of 7.69% by 2027 Fertility And Surgical Centers segment has highest cagr growth of 7.69%.

Fertility And Surgical Centers

Fertility And Surgical Centers segment was valued at US $0.55 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $1.06 billion by 2027. Fertility And Surgical Centers segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.42 billion opportunity in 2027 over 2021.

Hospitals And Clinics

Hospitals And Clinics segment was valued at US $0.67 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $1.30 billion by 2027. Hospitals And Clinics segment represented US $0.12 billion opportunity over 2019-2021 and estimated to create US $0.51 billion opportunity in 2027 over 2021.

Cryobanks

Cryobanks segment was valued at US $0.17 billion in 2019 and is projected to grow at 7.69% CAGR over the forecast period to reach US $0.33 billion by 2027. Cryobanks segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.13 billion opportunity in 2027 over 2021.